Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Change in Account Payables: 2022-2024

Historic Change in Account Payables for Lexeo Therapeutics (LXEO) over the last 3 years, with Dec 2024 value amounting to $2.4 million.

  • Lexeo Therapeutics' Change in Account Payables rose 132.27% to $394,000 in Q4 2023 from the same period last year, while for Dec 2023 it was -$180,000, marking a year-over-year change of. This contributed to the annual value of $2.4 million for FY2024, which is 1421.11% up from last year.
  • Latest data reveals that Lexeo Therapeutics reported Change in Account Payables of $2.4 million as of FY2024, which was up 1,421.11% from -$180,000 recorded in FY2023.
  • In the past 5 years, Lexeo Therapeutics' Change in Account Payables ranged from a high of $2.4 million in FY2024 and a low of -$426,000 during FY2022.
  • In the last 3 years, Lexeo Therapeutics' Change in Account Payables had a median value of -$180,000 in 2023 and averaged $590,667.
  • Data for Lexeo Therapeutics' Change in Account Payables shows a peak YoY soared of 1,421.11% (in 2024) over the last 5 years.
  • Lexeo Therapeutics' Change in Account Payables (Yearly) stood at -$426,000 in 2022, then surged by 57.75% to -$180,000 in 2023, then spiked by 1,421.11% to $2.4 million in 2024.